Pressurl: https://news.google.com/rss/articles/CBMirgFBVV95cUxOLThWaUpDWUMtNE9zQVotaldPX0tneC1yVXZ5NDlqRzd2amZZNTFVOFZOVTJ1NVV3Z3pHWXFTSzZqUGlnbE1aLU9iSW5BeUdpdmpzcGtUcEJpVkJ5cm1NUDBDZ2FyR3JZa0dCb0JxMlpnUV83RHp2Uy1JWTZiaDVLODhVZUJYa1JyM0k4SEFRWUVCZ0ZGVTcta3Rud0RMZ29uTDBNOTV0OWlTeWdac3c?oc=5 · headline: Exclusive: Drug discovery startup General Proximity raises $8M seed · publication: Axiosgoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMitAFBVV95cUxQdGZBSDAxV1V0TlNVMVRjUWxLRzRvSkVBcnA3TzlvYlhrV0ZaSnFmbHd2ZGNWTlNOVlgtaUNJZ2Z0UGpaX3FLbXlGOFVWeWNGSDZraWVXMDBFdUZQNjFJamhwMGN4eElnOHpjWkVaNVlWU29nN1JYOWNkMl9mZHpHQjZra05CcEczZ0RvRkdTS0w1aDNZejBzNnY2VlVfTWNUOUJyZXZkSWkzUEN1SXFCb2ZraUE?oc=5 · headline: General Proximity emerges to advance ‘proximity medicines’ for longevity and more · publication: Longevity.Technologygoogle_news · 10/15/2026
Pressurl: https://news.google.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?oc=5 · headline: General Proximity: $16 Million (Seed) Raised To Innovate Induced Proximity Medicines For Undruggable Targets · publication: Pulse 2.0google_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMiU0FVX3lxTE1oWmVBZkpsSzNrb2hjOUc3V0pRNDdZTFBPX3paeVpNajJtbEh4UkFGOFNvT3FzOXVEREdJMGJTR0NDTkpKY1lIY2JUeGZuTzFNWndZ?oc=5 · headline: General Proximity steps out of stealth to tackle undruggable targets · publication: FirstWord Pharma
google_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMikgFBVV95cUxPY2JNQkJPd2hVWnFsNDlIY1BtRGx0UUlaTUlIN2d2b0g2TTJCNm1pSTY0RllrZ2hTSV90Mzd0UXNodjRhR0tuMHRIbFVXSlBfWVZrRHNJdThEX2ZtVWY4UDRlMVNuNlNfUGJodXRybnF0TVdIMUJ4MndKcGVSMnptY0lEZmZCQWs4SjlwM3dSQkN2QQ?oc=5 · headline: Biotech platform General Proximity lands $16m seed · publication: Venture Capital Journalgoogle_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMirgJBVV95cUxOemR0RWwzMzRYVzhlc2FHWEJBN2pYMTVpUDl0MnV6TnZPdl9FeENZTXhLUXo3bm9rQWRfMmxHQnpuYVpUbHJsaUhBb0g2UGdZSk9PQzAybUd4ejBlaEgweXQySktZNGw5RnhwT0Zxb19qWERyWTltQVBVQlhWem5HN2pWYVB5c3d6dUNwaDNWOVhDUnVEQXFtYVZ6ajFLbklEc3A2cTljVnpqWHh4ZmlWRjFTSHU3N2plU29ua25vd2l4T0hxQmc3ZnF1WjdWVjlpVTRDbHI3N2E1anpkeUdDWmR0LVpGb0RRT3VrVVpJSVc1dE1WczQzaDhscjlnZFY0SGRqdkRkRG51Y3VyUFM2OGFBMl9fdzdmNkhuNEFqeWFmTnZnLUZHWVQtblFCZw?oc=5 · headline: General Proximity Announces Multi-Target Collaboration with Daiichi Sankyo to Discover and Advance Novel Oncology Therapeutics Using OmniTAC™ Platform · publication: PR Newswiregoogle_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMikwFBVV95cUxQNXpUU1pzTy1yNk8wMlpaZGhtR2JJZGlVTlItcXNmcFNGQjhBVG5XSWVSYVVCd004aUVwWjVJdWI0Nno0b3BqYUNiUnVDbEVlV3pqREFBU05ES0NrM09Xb3FkRWxpdC1oVTFIVVBXZWV6MF9zd0o0eDNzTkRDZU5rbTNyM0FXUXFjU1Z3MkdaZjFNOGc?oc=5 · headline: General Proximity and Daiichi Sankyo collaborate on oncology · publication: Pharmaceutical Technologygoogle_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMirAFBVV95cUxOTnBsY3ViazJvek5heWlWdTU0V082QXd6UERtNTlrdkIyUGh4SUlMRi1qU3hSaUJ5MWtEZ2JUZzM5MFZ6dkMwLWVEMGR1d2tqb25LTkNPOHIzRWJ1ZGRvaTA1WGdkQmpJdVhidHBCN2tOelg1RUNxQS1fVUFVLTJhRmdvZTg1RDhBZmw3dWRkWGwxNFJLRlhEWl9WTkVKS1hjVWEtMjRFUUM3a1lq?oc=5 · headline: FreeMind Investments Backs General Proximity in Strategic Biotech Bet · publication: citybizgoogle_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMi-gFBVV95cUxNLXY2RnJyRURkRlAyWE5uVl8tMElqNzgyMFFvM3lvYmZSTlVCNGhrS0V6S0VPRS1EQXpPTm1zdW9Jc09pMkExVU9oRW5aeTNDSFE2TmNtZTBFUURoY21DTjJ5WUl3bnhfWGRrdVFEajlLeVNKYnUtZmtDamdVUlpZVzYzYU5pU0FoejJqLUVYMkUyaE9CYVJvcElhRTBMUWtXYTBrYldxNWZKZEtvNGp5d3FtVDRDQUlEY2hoVGhiNkVtVUxadDZ4a0hUajVNRlNFLXpiSzJvMUsyWXhHMHRVVk1sTTN4Z0hNNTJqb184dzdNYlo3c1hNN0NB?oc=5 · headline: General Proximity De-Stealths with $16M to Pioneer Next-Gen Induced Proximity Medicines for 'Undruggable' Targets · publication: PR Newswiregoogle_news · 9/15/2026